Howard Hughes Medical Institute’s Synchrony SYF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-78
Closed -$6.51K 420
2025
Q4
$6.51K Sell
78
-2
-3% -$153 ﹤0.01% 290
2025
Q3
$5.68K Sell
80
-4
-5% -$290 ﹤0.01% 309
2025
Q2
$5.61K Buy
+84
New +$4.7K ﹤0.01% 302
2017
Q3
Sell
-72,227
Closed -$2.15M 109
2017
Q2
$2.15M Buy
72,227
+19,408
+37% +$575K 0.39% 51
2017
Q1
$1.81M Buy
+52,819
New +$1.89M 0.33% 59
2015
Q1
Sell
-8,124
Closed -$242K 193
2014
Q4
$242K Buy
+8,124
New +$225K 0.06% 123

Other funds holding SYF

Howard Hughes Medical Institute's SYF Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Synchrony (SYF) in Q1 2026, closing a stake of 78 shares — an estimated $6.51K sold.

Howard Hughes Medical Institute first reported a position in SYF in Q4 2014 and held it in 6 quarters. The position peaked at $2.15M in Q2 2017. 962 funds tracked by Wall St. Rank hold SYF as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Synchrony position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 78 Synchrony shares in Q1 2026, an estimated $6.51K.
  • Howard Hughes Medical Institute first reported a position in Synchrony in Q4 2014 and held it in 6 quarters.
  • Howard Hughes Medical Institute's Synchrony position peaked at $2.15M in Q2 2017.
  • 962 funds tracked by Wall St. Rank held Synchrony as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.